2:12 AM
 | 
May 23, 2018
 |  BC Extra  |  Financial News

Lava raises €16M for gamma delta T cell platform

Lava Therapeutics B.V. ('s-Hertogenbosch, the Netherlands) raised €16 million ($18.8 million) in a series B round led by Gilde Healthcare and Versant Ventures. Also participating were MRL Ventures Fund, Lupus Ventures and Biox Biosciences. Lupus and Biox invested in the company's...

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >